According to our (Global Info Research) latest study, the global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market size was valued at US$ 2225 million in 2025 and is forecast to a readjusted size of US$ 3314 million by 2032 with a CAGR of 6.2% during review period.
Pharmaceutical grade HCO (hydrogenated castor oil) is a high-purity excipient derived from the catalytic hydrogenation of refined castor oil, primarily consisting of glycerol tris(12-hydroxystearate). It is produced under stringent GMP standards and is characterized by its superior chemical stability and hydrophobic properties, making it an essential lubricant, stiffening agent, or matrix-former for controlled-release systems. This report primarily focuses on pharmaceutical-grade HCO and its derivatives, such as Polyoxyl Hydrogenated Castor Oils (e.g., PEG-40 Hydrogenated Castor Oil), which are widely utilized as potent solubilizers and emulsifiers in liquid formulations. Compared to industrial grades, pharmaceutical-grade HCO and its derivatives must adhere to rigorous pharmacopoeia standards (such as USP, EP, or ChP), ensuring strict control over acid values, impurity profiles, and biocompatibility for patient safety. in 2025, global pharmaceutical grade HCO sales volume was 925,000 tons, with an average unit price of US$2,445 per ton and a gross profit margin ranging from 25% to 45%. The global pharmaceutical-grade HCO industry chain is based on upstream castor seed cultivation and castor oil production. Raw materials are mainly concentrated in regions rich in castor resources such as India, China, and Brazil. After hydrogenation, refining, and pharmaceutical-grade quality control, intermediate products are formed. In the midstream, fine chemical and pharmaceutical excipient companies with GMP systems complete deep processing, focusing on controlling impurities, peroxide value, and batch stability. Downstream, it is mainly used in the pharmaceutical field as a nonionic surfactant, solubilizer, and emulsifier, widely used in injections, oral liquids, soft capsules, and topical preparations. It also extends to medical nutritional preparations and some high-end medical device-related formulations. The overall demand is highly correlated with the global trend of generic drugs, biological agents, and premium formulations.
This report is a detailed and comprehensive analysis for global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical Grade HCO (Hydrogenated Castor Oil)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, Croda, Kao, Nikkol Group, Itoh OilChem, Nihon Emulsion, Corel Pharma Chem, Shanxi Dideu Medichem, Jayant Agro-Organics, Inner Mongolia Weiyu Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Base Type
Chemically Modified Type
Market segment by Formulations
Injectable
Oral Preparations
Other
Market segment by Application
Solubilizer
Emulsifier
Excipient
Others
Major players covered
BASF
Croda
Kao
Nikkol Group
Itoh OilChem
Nihon Emulsion
Corel Pharma Chem
Shanxi Dideu Medichem
Jayant Agro-Organics
Inner Mongolia Weiyu Biotech
Shanghai Better Chemical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Grade HCO (Hydrogenated Castor Oil), with price, sales quantity, revenue, and global market share of Pharmaceutical Grade HCO (Hydrogenated Castor Oil) from 2021 to 2026.
Chapter 3, the Pharmaceutical Grade HCO (Hydrogenated Castor Oil) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Grade HCO (Hydrogenated Castor Oil) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Grade HCO (Hydrogenated Castor Oil).
Chapter 14 and 15, to describe Pharmaceutical Grade HCO (Hydrogenated Castor Oil) sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Pharmaceutical Grade HCO (Hydrogenated Castor Oil). Industry analysis & Market Report on Pharmaceutical Grade HCO (Hydrogenated Castor Oil) is a syndicated market report, published as Global Pharmaceutical Grade HCO (Hydrogenated Castor Oil) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pharmaceutical Grade HCO (Hydrogenated Castor Oil) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.